Exploring the Potential Role of Palmitoleate as a Risk Factor for Atrial Fibrillation: Findings from a Mendelian...

Area of Science:

• Cardiovascular Research
• Metabolomics
• Genetic Epidemiology

Background:

• Atrial fibrillation (AF) risk factors remain incompletely understood.
• Existing research suggests a link between dietary fatty acid intake and AF occurrence.
• Further investigation into serum fatty acid levels and AF is crucial for understanding risk factors and primary prevention.

Purpose of the Study:

• To investigate the relationship between serum fatty acids and atrial fibrillation (AF).
• To identify specific fatty acids that act as risk factors or protective elements for AF.
• To explore the potential of serum fatty acids as biomarkers for AF risk.

Main Methods:

• Mendelian randomization (MR) was employed to assess the causal effect of fatty acids on AF.
• Serum fatty acids were extracted and quantified using Gas chromatography-mass spectrometry (GC-MS).
• Patients were categorized into AF and non-AF groups for comparative analysis.

Main Results:

• Palmitoleic acid was identified as a significant risk factor for AF (OR=1.35, 95% CI=1.19-1.50) post-correction.
• Alpha/gamma-linolenic acid demonstrated a protective effect against AF (OR=0.94, 95% CI=0.89-0.98).
• Elevated serum levels of palmitoleic and stearic acids were observed in the AF group compared to the non-AF group.

Conclusions:

• Serum palmitoleic acid concentrations were significantly higher in patients with atrial fibrillation.
• Specific fatty acids, notably palmitoleic acid, may play a role in the pathogenesis of atrial fibrillation.
• These findings contribute to understanding AF etiology and potential preventative strategies.